Grants and Contributions:
Title:
WHO Global Mpox Strategic Preparedness and Response Plan (SPRP)
Agreement Number:
7464116 P014842001
Agreement Value:
$1,000,000.00
Agreement Date:
Dec 16, 2024 - Mar 31, 2025
Description:
This project aims to contribute to the World Health Organization (WHO)’s global mpox response to stop and contain the current oubreak of mpox as a Public Health Emergency of International Concern (PHEIC), through coordinated global, regional and national efforts. With a targeted focus on priority groups and populations in situations of vulnerability, the project seeks to rapidly detect and control outbreaks, advance research and ensure equitable access to medical countermeasures, as well as minimize zoonotic transmission. Project activities include: (1) strengthening surveillance and detection through enhanced capacity reinforcement; (2) enhancing community protection, with a focus on addressing stigma and discrimination associated with mpox, particularly related to sexual orientation, gender identity and HIV status; and (3) providing safe and scalable care, including the protection of healthcare workers and patients.
Organization:
Global Affairs Canada
Expected Results:
The project’s ultimate outcome is to stop and contain outbreaks of transmission of mpox through coordinated global, regional and national efforts.
Intermediate outcomes:
(1) rapidly detect and control mpox outbreaks;
(2) advance research and ensure equitable access to countermeasures; and
(3) minimize zoonotic transmission.
Location:
Geneva, CH
Reference Number:
064-2024-2025-Q3-00147
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
3200000000000
Recipient Type:
Not-for-profit organization or charity
Recipient's Legal Name:
WHO - World Health Organization
Program:
International Development Assistance Program
Program Purpose:
The main purpose on the International Development Assistance Program is to reduce poverty for those living in countries where Global Affairs Canada engages in international development.